On track for commercial-scale production of actinium-225, which is crucial to a new class of targeted treatments for cancer Largest Series A in life sciences sector in Belgium to date; led by EQT Life Sciences Total of EUR 134 million raised including funding secured through EUR 7.2…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.